Profilo
Peter Pechan worked as a Vice President-Gene Therapy at LogicBio Therapeutics, Inc. in 2021.
Prior to this, he obtained a doctorate degree from Eberhard Karls Universität Tübingen.
Precedenti posizioni note di Peter Pechan
| Società | Posizione | Fine |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
Formazione di Peter Pechan
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Peter Pechan
